Ashray Gunjur. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsBenzimidazoles/administration & dosageCarbamates/administration & dosageCetuximab/administration & dosageClinical Trials, Phase III as TopicColorectal Neoplasms/drug therapyColorectal Neoplasms/geneticsColorectal Neoplasms/mortalityColorectal Neoplasms/pathologyHumansMutationProtein Kinase Inhibitors/administration & dosageProto-Oncogene Proteins B-raf/antagonists & inhibitorsProto-Oncogene Proteins B-raf/geneticsRandomized Controlled Trials as TopicSulfonamides/administration & dosageTreatment Outcome
Substances： See more » BenzimidazolesCarbamatesProtein Kinase InhibitorsSulfonamidesbinimetinibencorafenibBRAF protein, humanProto-Oncogene Proteins B-rafCetuximab
Year: 2019 PMID： 31607543 DOI： 10.1016/S1470-2045(19)30644-8
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316